Revenue: The sum of all revenue fields included for a company's operating activities.
Perspective Therapeutics, Inc. (CATX) had Revenue of $0.04M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$0.04M |
$-37.49M |
|
-- |
|
$0.04M |
|
$39.88M |
|
$-39.83M |
|
$1.55M |
|
$-38.28M |
|
$-38.28M |
|
$-38.28M |
|
$-38.28M |
|
$-37.49M |
|
$-38.28M |
|
$-39.83M |
|
$-39.22M |
|
73.81M |
|
73.81M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$148.39M |
|
$76.60M |
|
$118.58M |
|
$266.97M |
|
$28.68M |
|
$1.57M |
|
$31.26M |
|
$59.94M |
|
$207.03M |
|
$167.03M |
|
$207.03M |
|
74.34M |
|
| Cash Flow Statement Financials | |
$-82.48M |
|
$41.23M |
|
$10.30M |
|
$61.58M |
|
$30.63M |
|
$-30.95M |
|
$8.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.17 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-92632.52% |
|
-92632.52% |
|
-- |
|
-89030.20% |
|
-87186.02% |
|
$-95.23M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
7.17 |
|
12.56 |
|
-18.49% |
|
-22.92% |
|
-14.34% |
|
-18.35% |
|
$2.79 |
|
$-1.29 |
|
$-1.12 |
|